BNTX
BioNTech SE
NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY
$94.13
-1.69% today
Updated 2026-06-05
Market cap
$21.87B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-5.84
Dividend yield
—
52W range
$80 – $124
Volume
0.9M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F8.5
Quality
A2.0
Profitability
F7.7
Valuation
B+3/9
Piotroski F-Score
Weak
6.1
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$133.00
+41.30%
12-Month target
—
—
Intrinsic (DCF)
$153.17
Margin of safety
+28.59%
1 Strong Buy13 Buy5 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 6.11 — safe zone
+ 28.59% below intrinsic value
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -44.60%
- Negative free cash flow $-485.66M
- Revenue declining -35.40% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $17.31B | $3.82B | $2.75B | $2.76B | $2.81B | $2.3B |
| Net income | $9.43B | $930.30M | $-665.30M | $-1.09B | $-540.65M | — |
| EPS | — | — | — | — | $-5.84 | $-3.53 |
| Free cash flow | $13.21B | $4.67B | $-244.60M | $269.81M | $-485.66M | — |
| Profit margin | 54.50% | 24.36% | -24.18% | -39.59% | -44.60% | — |
Peer comparison
Smart narrative
BioNTech SE trades at $94.13. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 6.11, it sits in the safe zone. TTM revenue stands at $2.81B. with profit margins at -44.60%. Our DCF model estimates intrinsic value at $153.17.
Frequently asked questions
What is BioNTech SE's stock price?
BioNTech SE (BNTX) trades at $94.13, on a P/S of 7.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is BioNTech SE overvalued?
BioNTech SE carries a Smart Value Score of 35/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $153.17 versus the $94.13 price, a 28.6% margin of safety on a cash flow basis.
What is the price target of BioNTech SE (BNTX)?
The 12-month analyst consensus target is $133.00, about 41.3% above the current $94.13. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of BNTX by 2030?
Our research-backed model puts the 2030 base case at $273.54, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of BioNTech SE (BNTX)?
Our DCF model estimates intrinsic value at $153.17, a +28.6% margin of safety versus today's $94.13. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is BioNTech SE's revenue?
BioNTech SE's trailing twelve-month revenue is $2.81B, and our model projects it reaching about $5.68B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
BioNTech SE's Altman Z-Score is 6.11, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio7.80x
ROE-6.72%
Beta1.32
50D MA$94.78
200D MA$100.16
Shares out0.25B
Float0.11B
Short ratio—
Avg volume0.9M
Performance
1 week+0.00%
1 month-1.64%
3 months-2.72%
YTD-7.48%
1 year—
3 years—
5 years—